Crude Breaks the Script

Oil’s rebound is forcing investors to reconsider the clean weak-jobs, patient-Fed narrative.

Author

Elie Zakhour
August 11, 2026

Market Snapshot

Get a Top Job Offer, Guaranteed (or tuition is free) | Apply Here

📉 Banana Bits

Market News

The Strait, the Sale, and the $500 Billion Question

Monday was technically a down day, but calling it that feels like giving a parking ticket to a house fire’s neighbor. The S&P 500 eased 0.06% to 7,753.11, the Nasdaq slid 0.32%, and the Dow shed 0.11%, all within a bad sneeze of all-time highs, one week after the best weekly gain since April. Under the surface, though, the market was rotating like a rotisserie chicken.

Energy was the big mover, gaining 4.63% as Brent crude jumped nearly 5% past $86. The culprit is the same one it’s been all summer: the Strait of Hormuz, which handles roughly 20% of global oil flows and is currently seeing only a fraction of normal traffic, basically a Costco with one register open. Iran says a transit agreement with Oman is nearly done but won’t fully reopen the waterway until the U.S. meets demands on compensation and sanctions relief. President Trump, meanwhile, said the U.S. is “low-keying” negotiations as talks continue over reopening the strait.

That oil premium is why the Fed conversation is stuck in the upside-down. Friday’s jobs report showed the economy lost 23,000 jobs in July, which would normally have traders begging for cuts. Instead, with crude re-inflating everything it touches, markets now price roughly 52% odds the Fed hikes in September. The tiebreaker is tomorrow’s CPI print.

To be fair, the bulls HAVE receipts. Roughly 85% of the S&P 500 companies that have reported this quarter beat estimates, way above the ~68% long-run norm, helping explain why JPMorgan bumped its year-end target to 8,000. The catch: that’s only ~3% above Friday’s close, at the same ~20x forward multiple. Translation: the easy multiple expansion is done; earnings have to carry the team from here.

And Monday exposed how picky this market has become about who pays for the AI boom. Berkshire, funding itself with boring old cash flow, rose 2.4%. Intel, funding itself with your shares, dropped 4%. Nvidia reportedly working with Apollo, Blackstone, and other Wall Street giants on a $500B AI infrastructure financing package splits the difference: keep the build-out, bring in outside capital to help fund the bill. The week’s earnings slate (CoreWeave, Super Micro, Cisco, Applied Materials, Cerebras, Nebius) is one long referendum on that trade.

Peel Take: The market isn’t bearish on AI spending it’s bearish on being the one who pays for it. Cash-rich compounders get a bid, dilution gets a cover charge, and $500B of GPU debt gets handed to private credit like a group dinner check nobody read. Our take: until Wednesday’s CPI, everything is noise; if 3.4% (or lower) prints, records fall by Friday. If oil keeps this up and CPI runs hot, “September hike” goes from tail risk to base case.

What's Ripe

Vertex Pharmaceuticals (VRTX) 5.61% 

  • The $133B biotech ripped to an all-time intraday high of $546.17 after rival Sionna Therapeutics’ cystic fibrosis drug failed trial, sending SION down 92% and removing a major potential challenger to Vertex’s dominant CF franchise.

  • The timing is chef’s kiss: just last week Vertex beat Q2 and raised full-year guidance to $13.1-13.2B on CF strength, plus growth from Casgevy and its non-opioid painkiller Journavx.

  • Peel Take: Vertex didn’t do anything Monday, its competition simply exploded on the launchpad, and in pharma that counts as a growth strategy. A 30-year CF franchise doing $13B a year with zero functional rivals is the closest thing biotech has to a toll road. (Fun footnote: Vertex’s new antibody partner AbCellera also went +35% Monday on hot-flash data. Good week to be in the Vertex extended universe.)

Akamai Technologies (AKAM) 6.43% 

  • The $17B cloud-and-cybersecurity vet snapped back from last week’s post-earnings beatdown after UBS jacked its price target to $143 from $125.

  • The story’s gotten real: Q2 featured a $600M+ cloud infrastructure contract and Cloud Infrastructure Services revenue up 39% y/y, enough for Barron’s to declare Akamai “solidly part of the AI trade”.

  • Shares opened below Friday’s close at $107 and climbed nearly 10% off the lows to finish +6.43%... dip buyers ate well.

  • Peel Take: Akamai spent 25 years delivering everyone else’s content and about one week convincing Wall Street it can deliver GPUs too. A dot-com survivor rebranding as AI infrastructure at 16x forward earnings – while its neighbors trade at triple digits – is either the cheapest ticket left to the party or a reminder that some stocks are cheap for a reason.

What's Rotten

Coherent (COHR) 14.24%

  • The AI-optics darling opened up at $383 and then fell off a cliff, closing dead on its lows as traders locked in gains two days ahead of Wednesday's earnings report

  • The setup was extreme: shares had ridden the AI transceiver trade from a 52-week low of $84 to as high as $440 (a nearly 5x move), juiced last week by reports the U.S. may ban Chinese optical rivals.

  • Peel Take: Nothing broke… no downgrade, no guide-down, just a stock that quadrupled realizing it has to justify itself in 48 hours. That's the problem with momentum: when everyone's playing musical chairs into earnings, the music stops early. If Wednesday's print delivers, this was a gift; if it doesn't, this was a premonition.

Intel (INTC) 4.06%

  • Chipzilla launched a $15B common stock offering (up to $17.25B with the greenshoe) to fund AI compute, advanced packaging, and foundry expansion, roughly 3% dilution, announced while citing “unprecedented” AI demand.

  • Shares fell back below $100, snapping the vibes of a turnaround rally that has the stock up ~150% YTD and nearly 5x its 52-week low of $20.44.

  • The sale equals ~75% of Intel’s entire $20B capex budget for 2026.

  • Peel Take: “Demand has never been stronger” followed immediately by “can shareholders spot us $15 billion” is the corporate version of your friend flexing his portfolio and then Venmo-requesting you for the Uber. To be clear, raising equity after a 5x run is smart, sell high, fund the fabs, live to fight TSMC another day.

🧠 Technical Trip

Interview Q&A from Citi

👉 Want 1-on-1 recruiting help from Evercore bankers & 5,000+ top mentors? Apply to WSO Academy

🌟 Student Spotlight

A+ Equity Research Report 📊

Looking for a stellar example of what makes an equity research report stand out?

One of our WSO Academy students, Will Tracy, put together an impressive deep dive on Dick's Sporting Goods (DKS), covering valuation, catalysts, and key risks with the kind of insight that turns good pitches into great ones.

🦈 Deal Dispatch

M&A, IPOs, And Other Notable Transactions

Student Success Corner

Banana Brain Teaser

Previous

A company pays out 40% of its $60 million in net income as dividends. If it has 20 million shares outstanding, what is its annual dividend per share?

Answer: $1.20

Today

A company has 50 million shares outstanding at $40 per share. It uses $200 million of cash to repurchase shares at the current price. If net income stays unchanged, by approximately what percentage does EPS increase?

❝

You can’t predict. You can prepare.

Howard Marks

How Would You Rate Today's Peel?


Happy Investing,
Chris, Elie, Mitchell, Fernanda, Nick, & Patrick